Inventor
REED GUY L
US20 patents
⚠️ This page may combine multiple inventors who share the name “REED GUY L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GEN HOSPITAL CORP
9 patentsUS5582862ADec 10, 1996
Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
GEN HOSPITAL CORP26 citations92
US5773228AJun 30, 1998
Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto
GEN HOSPITAL CORP8 citations73
US5446132AAug 29, 1995
Thrombin-activated platelet protein-2 (TAPP-2)
GEN HOSPITAL CORP10 citations73
US5372812ADec 13, 1994
Composition and method for acceleration of clot lysis
GEN HOSPITAL CORP8 citations73
US5332665AJul 26, 1994
Species specific, high affinity monoclonal antibodies
GEN HOSPITAL CORP18 citations73
US6114506ASep 5, 2000
Composition and method for enhancing fibrinolysis
GEN HOSPITAL CORP14 citations70
US6576431B2Jun 10, 2003
Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
GEN HOSPITAL CORP1 citations62
US6280730B1Aug 28, 2001
Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
GEN HOSPITAL CORP1 citations62
US5831031ANov 3, 1998
Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
GEN HOSPITAL CORP1 citations62
HARVARD COLLEGE
4 patentsUS5854049ADec 29, 1998
Plasmin-resistant streptokinase
HARVARD COLLEGE18 citations83
US6534035B1Mar 18, 2003
Methods of inhibiting clot formation
HARVARD COLLEGE8 citations73
US5939540AAug 17, 1999
Platelet secretory transport protein
HARVARD COLLEGE7 citations73
US6210667B1Apr 3, 2001
Bacterial fibrin-dependent plasminogen activator
HARVARD COLLEGE4 citations62
TRANSLATIONAL SCIENCES INC
4 patentsUS9834614B2Dec 5, 2017
Method of increasing plasmin activity through antiplasmin conversion
TRANSLATIONAL SCIENCES INC2 citations71
US11345758B2May 31, 2022
Inhibition of vascular matrix metalloproteinase-9 to treat ischemic injury
TRANSLATIONAL SCIENCES INC0 citations60
US11236176B2Feb 1, 2022
Serpinf2-binding molecules and method of use thereof
TRANSLATIONAL SCIENCES INC0 citations60
US11078297B2Aug 3, 2021
Prophylaxis of thrombosis
TRANSLATIONAL SCIENCES INC0 citations60